PMS39 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN COSTA RICA

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72192-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)72192-1/fulltext
Title : PMS39 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN COSTA RICA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72192-1&doi=10.1016/S1098-3015(11)72192-1
First page : A309
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 352
Categories :
Tags :
Regions :
ViH Article Tags :